Insulet is trading 6.31% up at $157.49 after closing at $148.14 on September 2, 2026, with limited support from broader market gains.
- No September 2 company-specific announcement, earnings release, regulatory action, or analyst catalyst was identified.
- Latest quarterly results were released August 5; the next scheduled investor event is September 9.
- The broader market was modestly positive, including a 0.52% Nasdaq gain, providing limited global risk-on support.